Feasibility and acceptance of artificial intelligence-based diabetic retinopathy screening in Rwanda.

Journal: The British journal of ophthalmology
PMID:

Abstract

BACKGROUND: Evidence on the practical application of artificial intelligence (AI)-based diabetic retinopathy (DR) screening is needed.

Authors

  • Noelle Whitestone
    Clinical Services, Orbis International, New York, New York, USA.
  • John Nkurikiye
    RIIO iHospital, Rwanda International Institute of Ophthalmology, Kigali, Rwanda.
  • Jennifer L Patnaik
    Clinical Services, Orbis International, New York, New York, USA.
  • Nicolas Jaccard
    Department of Computer Science, University College London, London, UK.
  • Gabriella Lanouette
    Clinical Services, Orbis International, New York, New York, USA.
  • David H Cherwek
    Clinical Services, Orbis International, New York, New York, USA.
  • Nathan Congdon
    Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
  • Wanjiku Mathenge
    Clinical Services, Orbis International, New York, New York, USA ciku.mathenge@riio.org.